Overcoming Challenges in AAV and LV Viral Vector Manufacturing

Аватар автора
A-List Celebrity Spotlight
Overcoming Challenges in AAV and LV Viral Vector Manufacturing: A Platform Based Approach for Optimizing Timeline, Cost and Effort Into Clinics Watch our expert talking about our AAV and LV expertise and how we can help your team to design a seamless and scalable vector-production process. Learn more about - How to leverage innovative testing and manufacturing platforms to reduce timelines while increasing cost-savings for viral vector production - About the benefits of partnering with experienced CDMOs with AAV and LVV manufacturing experience - And more #LV Connect with us to stay up to date with the latest news from IDT Biologika:

0/0


0/0

0/0

0/0